Koninklijke Philips Pre-Tax Profit Margin 2012-2026 | PHG
Current and historical pre-tax profit margin for Koninklijke Philips (PHG) from 2012 to 2026. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Koninklijke Philips pre-tax profit margin for the three months ending June 30, 2026 was .
| Koninklijke Philips Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2026-06-30 | $20.58B | $1.70B | 8.27% |
| 2026-03-31 | $20.43B | $1.45B | 7.10% |
| 2025-12-31 | $20.18B | $1.34B | 6.63% |
| 2025-09-30 | $19.08B | $1.09B | 5.69% |
| 2025-06-30 | $18.86B | $1.47B | 7.80% |
| 2025-03-31 | $18.81B | $1.21B | 6.45% |
| 2024-09-30 | $18.97B | $0.38B | 1.98% |
| 2024-06-30 | $18.60B | $0.07B | 0.37% |
| 2023-06-30 | $18.89B | $-0.55B | -2.89% |
| 2023-03-31 | $18.85B | $-0.40B | -2.11% |
| 2022-06-30 | $19.63B | $0.71B | 3.59% |
| 2021-06-30 | $20.30B | $1.04B | 5.11% |
| 2020-06-30 | $19.93B | $1.17B | 5.87% |
| 2019-06-30 | $22.93B | $1.72B | 7.48% |
| 2018-06-30 | $24.26B | $1.65B | 6.81% |
| 2017-06-30 | $25.77B | $1.67B | 6.47% |
| 2016-12-31 | $27.13B | $1.54B | 5.67% |
| 2016-09-30 | $27.08B | $0.76B | 2.79% |
| 2016-06-30 | $26.99B | $0.71B | 2.64% |
| 2016-03-31 | $26.98B | $0.70B | 2.61% |
| 2015-12-31 | $26.92B | $0.69B | 2.57% |
| 2015-09-30 | $26.06B | $0.56B | 2.14% |
| 2015-06-30 | $26.93B | $0.06B | 0.23% |
| 2015-03-31 | $27.58B | $0.11B | 0.41% |
| 2014-12-31 | $28.44B | $0.25B | 0.87% |
| 2014-09-30 | $30.72B | $1.20B | 3.90% |
| 2014-06-30 | $30.80B | $1.92B | 6.23% |
| 2014-03-31 | $30.92B | $2.13B | 6.88% |
| 2013-12-31 | $30.99B | $2.21B | 7.12% |
| 2013-09-30 | $31.41B | $1.22B | 3.89% |
| 2013-06-30 | $31.96B | $1.03B | 3.22% |
| 2013-03-31 | $31.77B | $0.80B | 2.51% |
| 2012-12-31 | $32.19B | $1.01B | 3.13% |
| 2012-09-30 | $31.35B | $1.46B | 4.67% |
| 2012-06-30 | $30.80B | $1.42B | 4.61% |
| 2012-03-31 | $31.11B | $-0.64B | -2.05% |
| 2011-12-31 | $31.33B | $-0.71B | -2.26% |
| 2011-09-30 | $32.59B | $-0.10B | -0.30% |
| 2011-06-30 | $33.09B | $0.42B | 1.27% |
| 2011-03-31 | $33.49B | $2.57B | 7.67% |
| 2010-12-31 | $33.77B | $2.58B | 7.64% |
| 2010-09-30 | $34.44B | $1.17B | 3.40% |
| 2010-06-30 | $34.60B | $0.68B | 1.95% |
| 2010-03-31 | $34.14B | $1.37B | 4.00% |
| 2009-12-31 | $32.91B | $0.62B | 1.90% |
| 2009-09-30 | $32.42B | $-0.90B | -2.78% |
| 2009-06-30 | $33.85B | $-0.66B | -1.94% |
| 2009-03-31 | $36.52B | $-0.49B | -1.35% |
| 2008-12-31 | $38.81B | $0.14B | 0.35% |
| 2008-09-30 | $40.05B | $4.21B | 10.51% |
| 2008-06-30 | $39.47B | $4.25B | 10.76% |
| 2008-03-31 | $37.59B | $5.18B | 13.77% |
| 2007-12-31 | $36.50B | $6.12B | 16.77% |
| 2007-09-30 | $35.52B | $4.50B | 12.67% |
| 2007-06-30 | $34.61B | $4.02B | 11.61% |
| 2007-03-31 | $35.94B | $2.43B | 6.76% |
| 2006-12-31 | $36.96B | $1.53B | 4.13% |
| 2006-09-30 | $37.80B | $2.35B | 6.23% |
| 2006-06-30 | $39.05B | $3.04B | 7.79% |
| 2006-03-31 | $39.12B | $2.54B | 6.48% |
| 2005-12-31 | $38.95B | $2.35B | 6.03% |
| 2005-09-30 | $44.75B | $1.82B | 4.06% |
| 2005-06-30 | $44.29B | $2.23B | 5.02% |
| 2005-03-31 | $43.45B | $2.47B | 5.67% |
| 2004-12-31 | $43.03B | $2.47B | 5.74% |
| 2004-09-30 | $36.64B | $2.36B | 6.45% |
| 2004-06-30 | $35.68B | $1.03B | 2.88% |
| 2004-03-31 | $34.33B | $0.55B | 1.61% |
| 2003-12-31 | $33.02B | $0.31B | 0.93% |
| 2003-09-30 | $31.21B | $-0.56B | -1.78% |
| 2003-06-30 | $30.53B | $-0.70B | -2.28% |
| 2003-03-31 | $30.46B | $-2.00B | -6.55% |
| 2002-12-31 | $30.11B | $-1.90B | -6.29% |
| 2002-09-30 | $29.48B | $-2.68B | -9.10% |
| 2002-06-30 | $28.64B | $-2.91B | -10.17% |
| 2002-03-31 | $27.92B | $-2.21B | -7.92% |
| 2001-12-31 | $28.84B | $-2.03B | -7.03% |
| 2001-09-30 | $30.28B | $1.62B | 5.34% |
| 2001-06-30 | $32.42B | $3.60B | 11.11% |
| 2001-03-31 | $34.35B | $4.96B | 14.43% |
| 2000-12-31 | $35.03B | $5.86B | 16.72% |
| 2000-09-30 | $35.19B | $3.64B | 10.35% |
| 2000-06-30 | $34.86B | $2.57B | 7.38% |
| 2000-03-31 | $33.97B | $2.29B | 6.74% |
| 1999-12-31 | $33.40B | $1.80B | 5.39% |
| 1999-09-30 | $31.72B | $9.60B | 30.25% |
| 1999-06-30 | $31.79B | $17.46B | 54.93% |
| 1999-03-31 | $32.99B | $25.97B | 78.72% |
| 1998-12-31 | $33.89B | $33.89B | 100.00% |
| 1998-09-30 | $37.85B | $37.85B | 100.00% |
| 1998-06-30 | $38.92B | $38.92B | 100.00% |
| 1998-03-31 | $39.01B | $39.01B | 100.00% |
| 1997-12-31 | $39.13B | $39.13B | 100.00% |
| 1997-09-30 | $39.39B | $39.39B | 100.00% |
| 1997-06-30 | $39.63B | $39.63B | 100.00% |
| 1997-03-31 | $40.14B | $40.14B | 100.00% |
| 1996-12-31 | $40.97B | $40.97B | 100.00% |
| 1996-06-30 | $28.53B | $28.53B | 100.00% |
| 1996-03-31 | $28.47B | $28.47B | 100.00% |
| 1995-09-30 | $38.67B | $38.67B | 100.00% |
| 1995-06-30 | $37.11B | $37.11B | 100.00% |
| 1995-03-31 | $35.48B | $35.48B | 100.00% |
| 1994-12-31 | $33.79B | $33.79B | 100.00% |
| 1994-06-30 | $22.52B | $22.52B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $24.474B | $20.173B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $176.551B | 19.40 |
| Medtronic (MDT) | Ireland | $119.919B | 16.39 |
| Stryker (SYK) | United States | $107.976B | 20.18 |
| EssilorLuxottica (ESLOY) | France | $77.566B | 0.00 |
| Boston Scientific (BSX) | United States | $63.578B | 13.67 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.123B | 0.00 |
| Agilent Technologies (A) | United States | $42.365B | 24.80 |
| Medline (MDLN) | United States | $42.215B | 0.00 |
| ResMed (RMD) | United States | $33.097B | 20.54 |
| GE HealthCare Technologies (GEHC) | United States | $28.940B | 13.84 |
| Terumo (TRUMY) | Japan | $21.278B | 20.32 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.771B | 11.60 |
| Baxter (BAX) | United States | $12.258B | 11.57 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.762B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.107B | 40.73 |
| Demant (WILYY) | Denmark | $9.694B | 0.00 |
| Insulet (PODD) | United States | $9.657B | 23.72 |
| Sunny Optical Technology (SNPTF) | China | $9.142B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.575B | 20.23 |
| Raia Drogasil SA - (RADLY) | $4.998B | 0.00 | |
| BillionToOne (BLLN) | United States | $4.920B | 148.96 |
| Haemonetics (HAE) | United States | $4.832B | 21.20 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| Envista Holdings (NVST) | United States | $3.972B | 16.82 |
| ICU Medical (ICUI) | United States | $3.896B | 23.27 |
| AtriCure (ATRC) | United States | $2.860B | 244.43 |
| Neogen (NEOG) | United States | $2.672B | 47.12 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| Curaleaf Holdings (CURLF) | United States | $2.363B | 0.00 |
| Trulieve Cannabis (TRLV) | United States | $2.234B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.214B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.211B | 10.56 |
| Perrigo (PRGO) | Ireland | $1.882B | 5.42 |
| LeMaitre Vascular (LMAT) | United States | $1.835B | 29.50 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.787B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.780B | 227.44 |
| Kestra Medical Technologies (KMTS) | United States | $1.500B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.445B | 15.42 |
| Phibro Animal Health (PAHC) | United States | $1.422B | 10.91 |
| Omeros (OMER) | United States | $1.243B | 6.29 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.131B | 0.00 |
| CeriBell (CBLL) | United States | $0.961B | 0.00 |
| InMode (INMD) | Israel | $0.855B | 11.90 |
| AdaptHealth (AHCO) | United States | $0.794B | 16.63 |
| VAREX IMAGING (VREX) | United States | $0.778B | 17.10 |
| Glass House Brands (GLAS) | United States | $0.754B | 0.00 |
| QuidelOrtho (QDEL) | United States | $0.729B | 7.87 |
| Valneva SE (VALN) | France | $0.622B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.561B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.543B | 0.00 |
| Brainsway (BWAY) | Israel | $0.541B | 30.59 |
| Evolus (EOLS) | United States | $0.522B | 0.00 |
| Cerus (CERS) | United States | $0.504B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.498B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.441B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.413B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.372B | 0.00 |
| SNDL (SNDL) | Canada | $0.347B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.333B | 24.31 |
| Sanara MedTech (SMTI) | United States | $0.323B | 159.59 |
| TriSalus Life Sciences (TLSI) | United States | $0.294B | 0.00 |
| MacroGenics (MGNX) | United States | $0.257B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.248B | 13.17 |
| OraSure Technologies (OSUR) | United States | $0.239B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.238B | 22.75 |
| High Tide (HITI) | Canada | $0.226B | 50.80 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.200B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.192B | 0.00 |
| Exagen (XGN) | United States | $0.181B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.156B | 0.00 |
| Organigram Global (OGI) | Canada | $0.149B | 0.00 |
| Quanterix (QTRX) | United States | $0.129B | 0.00 |
| Apyx Medical (APYX) | United States | $0.125B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| FitLife Brands (FTLF) | United States | $0.087B | 11.48 |
| ImmuCell (ICCC) | United States | $0.087B | 119.75 |
| Accendra Health (ACH) | United States | $0.085B | 4.83 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.056B | 0.00 |
| Hongchang (HCIL) | China | $0.055B | 0.00 |
| Biote (BTMD) | United States | $0.050B | 4.09 |
| Nephros (NEPH) | United States | $0.047B | 39.00 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.035B | 17.12 |
| United-Guardian (UG) | United States | $0.033B | 13.22 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.022B | 0.00 |
| Modular Medical (MODD) | United States | $0.020B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |